CEO @RedLightHolland parent co of @filamenthealth 🍄 💊 CSE: $TRIP | OTC: $TRUFF - PEX010 patented psilocybin botanical drug candidate.
Joined August 2009
- Tweets 31,837
- Following 2,250
- Followers 37,935
- Likes 13,678
5,215 Photos and videos
Pinned Tweet
Apr 21
Thanks to @traderTVLIVE for having me on to talk about 🇺🇸 fast tracking access to psychedelics and our company $TRIP CSE | $TRUFF OTC 🙏
1
5
15
2,255
20h
I’m surprised you haven’t created a rocket landing emoji yet. Oh wait. I got @grok to do it!
1
4
363
Todd retweeted
Esse lance SĂ“ MELHORA
Antes do árbitro dar a bola pro Dylan Harper cobrar o lateral
O Karl-Anthony Towns pede pra dois torcedores que estavam em pé, dar alguns passos pro lado pro Harper ter menos espaço
GĂŞnio da malandragem
Vocês não fazem noção de quanto o Karl-Anthony Towns salvou awui
O Knicks ia tomar o game winner do Stephon Castle se ele nĂŁo devia esse passe
77
486
13,386
1,757,458
Todd retweeted
The most most clinically disregarded drug in the last 20 years - MAGIC MUSHROOMS (psilocybin)
Clinically backed use cases:
1. Treatment-resistant depression
2. End-of-life anxiety in cancer patients
3. Alcohol use disorder
4. Tobacco addiction
5. Early case-study signal in Alzheimer's
Mechanism:
- psilocybin activates 5-HT2A serotonin receptors and quiets the default mode network (Rigid patterns loosen)
- BDNF (your brain's growth factor) spikes
- New neural connections form
- Effects from one dose can last weeks to month
How to dose correctly and safely:
- A clinical or legally sanctioned setting, not recreational
- Trained therapist for preparation, the session itself, and integration afterwards
- Medical screening
- Set and setting matter as much as the molecule
The clinical results come from a controlled context
Exciting science
Jun 4
“Psilocybin, the psychedelic component of magic mushrooms, has previously been touted as an effective treatment for depression, anxiety, addiction, and PTSD — but now researchers say it has the potential to be used in Alzheimer’s intervention as well.
In this case study, published in Frontiers in Neuroscience, researchers focused on an 80-year-old Japanese American woman with Alzheimer’s. She had declined over the previous decade and was reduced to urinary incontinence, speaking in single syllables, and dependence on caregivers for mobility support and daily living.
She was then given a 5g dose of magic mushrooms.
During the initial phase, she was agitated, sweated profusely and entered a prolonged sleep state that suggested unconsciousness. But around hour 19, she began speaking in full autobiographical sentences, recalling life events she had been unable to articulate for years.
In the days and weeks that followed, more incredible changes emerged. She regained urinary continence, even in the evenings, and began dressing herself. She was able to make and maintain eye contact, remember social interactions, emotionally respond to others, and hold lucid conversations.”
1
7
44
3,903
Todd retweeted
psilocybin assisted therapy for cocaine dependence full paper
jamanetwork.com/journals/jam…
11
49
4,828
Jun 4
Separately @redlightholland & @filamenthealth are proud to do our part with PEX010 and @UCSF to discover more. newsfilecorp.com/release/300…
Jun 4
“Psilocybin, the psychedelic component of magic mushrooms, has previously been touted as an effective treatment for depression, anxiety, addiction, and PTSD — but now researchers say it has the potential to be used in Alzheimer’s intervention as well.
In this case study, published in Frontiers in Neuroscience, researchers focused on an 80-year-old Japanese American woman with Alzheimer’s. She had declined over the previous decade and was reduced to urinary incontinence, speaking in single syllables, and dependence on caregivers for mobility support and daily living.
She was then given a 5g dose of magic mushrooms.
During the initial phase, she was agitated, sweated profusely and entered a prolonged sleep state that suggested unconsciousness. But around hour 19, she began speaking in full autobiographical sentences, recalling life events she had been unable to articulate for years.
In the days and weeks that followed, more incredible changes emerged. She regained urinary continence, even in the evenings, and began dressing herself. She was able to make and maintain eye contact, remember social interactions, emotionally respond to others, and hold lucid conversations.”
1
10
1,063
Todd retweeted
May 27
A clinical trial led by Peter Hendricks, Ph.D., shows that psilocybin, a naturally occurring psychedelic compound in magic mushrooms, is safe and effective in treating cocaine use disorder, or CUD. @UABHeersink
Learn more: buff.ly/eIhLufa
1
9
34
2,095
Todd retweeted
May 22
Despite billions of dollars spent on potential drug treatments for cocaine addiction, none have proved effective—and cocaine use is increasing in the United States and around the world.
But one class of possible remedy has remained untested: psychedelics, which have shown promise for treating post-traumatic stress disorder, depression, anxiety, alcohol use disorder, smoking, and more.
Now, the results of a pioneering randomized trial—more than a decade in the making—reveal a single dose of psilocybin, the psychedelic component of magic mushrooms, brought significant relief for people addicted to cocaine.
The study of 40 people showed that 180 days after treatment, 30% of the psilocybin group was completely abstaining from cocaine, versus none of the placebo group—and those who continued using the drug did so less frequently.
Learn more: scim.ag/3Rk7gdq @NewsfromScience
11
33
122
22,738
Todd retweeted
May 21
May is Lyme Disease Awareness Month, a time to recognize the growing impact of Lyme disease and other tick-borne illnesses on American families and communities. Lyme disease now affects an estimated 476,000 Americans each year and remains one of the most common vector-borne diseases in the United States.
I recently wrote to the House Energy & Commerce Committee urging support for reauthorization of the Kay Hagan Tick Act to strengthen research, surveillance, early detection, treatment, and public awareness efforts related to tick-borne disease.
Thank you to Chairman @RepGuthrie, Ranking Member @FrankPallone, and the House Energy & Commerce Committee for advancing this important bipartisan legislation.
1,616
1,514
5,629
338,318
May 19
May 19
1
12
2,090
May 18
💊 @Redlightholland’s wholly owned subsidiary @filamenthealth Holds the Exclusive License to the Data and Intellectual Property in this Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, featured below in @guardiannews
theguardian.com/science/2026…
1
2
9
1,198
Todd retweeted
Tim Sparks has purchased 80 pizza huts and is bringing back their iconic looks and nostalgic feel
The salad bar, Pac-Man, the OG red cups, family booths, the lighting, and more will all make a return
"I want to rebuild places for families to connect and put their phones down"
506
1,757
17,575
736,652
Todd retweeted
A single dose of #psilocybin was associated with rapid reduction in depressive symptoms in adults with major depressive disorder, with effects persisting beyond 3 months on secondary measures. ja.ma/4uhzmol
ALT RCT: Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression. Population: 14 Males, 21 Females, adults 20-65 y. Intervention: 35 Participants randomized, 17 Psilocybin, 18 Niacin. Findings: improvement in MADRS scores on day 8.
14
50
2,762
Todd retweeted
May 13
Psilocybin (the active compound in magic mushrooms) may slow cellular aging.
A recent research published in npj Aging is revealing surprising anti-aging effects of psilocybin at the biological level — well beyond its known psychological benefits.
Found naturally in species like Psilocybe cubensis, the compound is now being studied for its ability to strengthen cellular structures, improve metabolic health, and slow the biological processes associated with aging. While longevity research has long focused on diet, exercise, and supplements, this emerging science points to a bold new possibility: using psychedelics to enhance cellular resilience.
Although large-scale human trials are still in early stages, the preliminary findings are generating considerable excitement in both scientific and wellness communities. Researchers are now exploring how psilocybin interacts with key aging pathways, potentially opening the door to new preventative strategies for healthier, more vital aging.
This represents a broader shift in biotechnology, re-examining once-stigmatized substances for their genuine therapeutic potential in tackling some of humanity’s biggest biological challenges.
[npj Aging. (2024). Psilocybin and Cellular Resilience: Emerging Perspectives in Longevity Science. Nature Portfolio]
24
83
309
27,469
May 8
$TRIP $TRUFF news:
@RedLightHolland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with @FilamentHealth Holding the Exclusive License to the Data and Intellectual Property
newsfilecorp.com/release/296…
2
18
1,305
at @redlightholland working (post aquasition) with @FilamentHealth, the amount of psychedelic research and patients they help is starting to sink in! newsfilecorp.com/release/296…
2
11
592
Todd retweeted
Science gets closer to understanding how a psychedelic trip changes the brain nbcnews.com/health/health-ne… via @nbcnews
4
19
112
5,062